Short professional biography (maximum 50 words) Please write in third person.
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Your practice details
When answering the below questions, please refer to your main place of practice.
How remote is your main place of practice? If unsure, please provide your best guess.
How would you best describe the service setting?
On average, how many people with chronic hepatitis C do you personally see each month in your practice? Please enter a whole number. If unsure, please provide your best estimate.
On a scale of 1-4, how experienced are you at prescribing direct-acting antiviral (DAA) therapy for patients with chronic hepatitis C?
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Abstract Submission
Click here to view abstract guidelines
Bianca.Leber@ashm.org.au or +61 435 799 237. She will support you with this process and if required can also put you in touch with a member of the Forum GP Advisory Panel for additional guidance.
Abstract Title
Preferred presentation type
Preferred presentation type
Authors
All authors must be listed with their first name, any initials and surname, with commas between each name
Principal author to appear first.
Omit degrees and titles
Include affiliations/organisation for each author (i.e. department, institution, city, country). Use parenthetical numbering after the author’s name to indicate affiliations
Example:
BELINDA SMITH (1), WILLIAM H. TAYLOR (1,2)
(1) University of NSW, Sydney, Australia, (2) Australasian Professional Society on Alcohol and other Drugs, Sydney, Australia
Please provide a disclosure of interest statement for any contributions received relevant to this work.
For example: “The author has received support from Gilead and AbbVie to attend and present at hepatitis C educational events within Australia."
No presenter fee will be paid to successful participants. By submitting an abstract all authors agree to release the license to the forum organisers and give permission to publish the abstract in the forum handbook and ASHM website, and in so doing certify that the abstract is original work.
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Oral and multimedia presentations - body of abstract
Body of abstract must not exceed 300 words total. Please structure your submission using the subheadings below. If the abstract does not fit the headings, please put full abstract beneath Background. Please ensure any patient information is de-identified.
Background
Outline the challenge/s identified in managing hepatitis C within your clinical setting.
Approach
Outline the strategy developed to address the challenge.
Outcome
Provide information highlighting how your strategy has assisted in the management of hepatitis C within your clinical setting. What observations and/or measured outcomes have resulted from utilisation of your strategy?
Applications
How can your approach be applied in primary health care settings? Highlight the novelty of the work and how it contributes to improving management of hepatitis C in primary health care.
Interactivity
Will your presentation be interactive, e.g. incorporate audience questions and discussion points?
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Scholarship Application 2021 Viral Hepatitis Conference
Scholarship Inclusions:
Limited scholarships will include registration for day one of the Australasian Viral Hepatitis Conference . Your attendance can be either in-person or online.
If attending in-person, r eturn flights (as per availability & best fare of the day)
If attending in-person, t wo nights accommodation to attend day one of the Australasian Viral Hepatitis Conference only
Scholarship Exclusions:
All ground transport; all meals; additional accommodation nights or room upgrades; and any incidentals.
Please Note:
Reimbursements cannot be provided for travel, accommodation or registration fees that have been already paid for. We will book and pay for these directly to the supplier on your behalf.
Scholarship applicants will be excluded if they have access to the following:
Funds from a research grant to cover attendance at this meeting
Access to TESL OR an equivalent professional development fund
Funding from a pharmaceutical or other industry partner
Financial support from your employer
Upon acceptance of my abstract, I would like to be considered for a scholarship to attending the 2021 Viral Hepatitis Conference:
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Scholarship Application 2021 Viral Hepatitis Conference (continued)
W hat level of support you are applying for (select all that apply):
Registration (Viral Hepatitis Conference)
How would you like to attend
Have you received an ASHM scholarship before?
How will you share information with colleagues after the conference?
ASHM requires that scholarship holders do not have access to any other form of financial support to attend this meeting. Please confirm that you do not have access to any other form of financial support to attend the 12th Australasian Viral Hepatitis Conference.
I do not have funds from a research grant to cover attendance at this conference
I do not have access to TESL or equivalent professional development fund in my state
I do not have funding from a pharmaceutical or other industry partner
I do not have financial support from my employer
ASHM requires that scholarship holders report back from any conference they are supported to attend through social media or short blog posts. An ASHM staff member will provide instructions and assistance with this process.
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Thank you for your application. An ASHM staff member will be in touch in April to advise whether you have been successful.
Cancel
Back
Cancel
Cancel Registration
Submit
Submit
Return to summary